Cipro tablets contain ciprofloxacin, a fluoroquinolone antibiotic taken by mouth for selected bacterial infections. It is prescribed mainly for adults when the suspected organism is susceptible…
Cipro tablets contain ciprofloxacin, a fluoroquinolone antibiotic taken by mouth for selected bacterial infections. It is prescribed mainly for adults when the suspected organism is susceptible, including certain urinary, gastrointestinal, respiratory, bone, joint, or systemic infections. Ciprofloxacin stops bacterial DNA replication, which prevents the organism from multiplying.
Cipro contains ciprofloxacin, a fluoroquinolone antibiotic available as tablets. How much to use and how often depends on the purpose of use and is agreed with a doctor or pharmacist.
Cipro is supplied as oral tablets containing ciprofloxacin. How much to use and how often depends on the purpose of use and is agreed with a doctor or pharmacist.
Cipro may be prescribed for selected bacterial infections in adults, with the precise indication depending on the organism, infection severity, kidney function, and local prescribing guidance. The European Medicines Agency restricts fluoroquinolone use when other suitable antibiotics can treat the infection with less risk.[2]
Ciprofloxacin can be used for selected complicated urinary tract infections, acute pyelonephritis, and chronic bacterial prostatitis when the causative organism is susceptible. It is not automatically the first choice for uncomplicated cystitis, because resistance and fluoroquinolone-related adverse effects affect treatment selection.
Kidney infection can cause fever, flank pain, nausea, and marked urinary symptoms. Such features require clinical assessment rather than self-treatment with leftover antibiotics.
Some lower respiratory tract infections, including selected bacterial bronchitis cases, may be treated with ciprofloxacin when microbiology and prescribing guidance support its use. Its activity against common respiratory pathogens is limited, so another antibiotic may be more appropriate.
Ciprofloxacin may also be selected for certain bacterial gastrointestinal infections, including infections caused by susceptible Gram-negative organisms. Diarrhoea following antibiotics can represent ordinary disturbance of gut flora, but persistent or bloody diarrhoea needs prompt medical assessment.
Ciprofloxacin has specialised uses involving organisms such as Pseudomonas and may be included in post-exposure management for inhalational anthrax under public-health direction. Q fever and other unusual infections require organism-specific treatment; ciprofloxacin should not be assumed to be suitable simply because a bacterial illness is suspected.
Ciprofloxacin tablets should be swallowed with water. They should not be taken at the same time as antacids or mineral supplements containing calcium, magnesium, aluminium, iron, or zinc. A practical separation interval is usually required, and the exact timing should be arranged with the prescribing pharmacist or doctor.
Do not crush or chew a modified-release ciprofloxacin tablet if such a formulation has been prescribed. Regular and modified-release products are not interchangeable by appearance alone.
How much to use and how often depends on the purpose of use and is agreed with a doctor or pharmacist.
Typical administration principles include:
Severe kidney impairment may require a lower dose or a longer interval. Older adults, people with a history of tendon disorders, and patients taking corticosteroids need careful risk assessment before treatment.
Food does not create the same absorption problem as mineral products. Milk, yoghurt, fortified drinks, and supplements containing calcium can interfere when taken alongside the tablet, so timing matters.
Cipro is not suitable for everyone. It should not be used by people with a previous serious allergic reaction to ciprofloxacin or another quinolone antibiotic. It is also contraindicated with tizanidine.
Extra caution or an alternative may be needed in people with:
A history of fainting, known QT prolongation, low potassium, or treatment with several rhythm-affecting drugs requires specific review.[3]
This medication is not for you if you have had a serious tendon, nerve, psychiatric, allergic, or cardiac reaction to ciprofloxacin or another fluoroquinolone.
Common effects can include nausea, diarrhoea, abdominal discomfort, headache, dizziness, sleep disturbance, and changes in taste. Many are mild, yet a reaction can become clinically significant when it affects tendons, nerves, the heart rhythm, or mental state.
Stop taking the next dose and obtain urgent medical advice if you develop:
Tendon injury can appear during treatment or months afterwards. The risk is higher in older adults, people with kidney disease, transplant recipients, and patients taking corticosteroids. Physical training should be reduced if tendon pain appears.
Ciprofloxacin may cause dizziness or impaired concentration. A patient who feels unsteady should avoid driving, cycling on busy roads, climbing, or operating machinery until the effect has settled.
The medicine acts inside susceptible bacteria rather than directly relieving pain, fever, or inflammation. Its antibacterial effect depends on blocking enzymes required for the organisation and repair of bacterial DNA.[1]
Ciprofloxacin inhibits DNA gyrase and topoisomerase IV. These enzymes allow bacterial DNA to twist, separate, and copy correctly during cell division. When the enzymes are blocked, damaged DNA accumulates and the bacterium loses its ability to reproduce.
The result is usually bactericidal activity, meaning the drug kills susceptible bacteria rather than merely slowing their growth. The effect differs from bacteriostatic treatment, which mainly limits multiplication while the immune system clears the remaining organisms.
Several habits reduce the chance of a good result or increase avoidable risk:
One easily missed detail is the mineral interaction. A morning multivitamin can be enough to reduce ciprofloxacin absorption if both are taken together.
Ciprofloxacin is selected by infection pattern and susceptibility rather than by tablet strength alone. The closest alternative may belong to a different antibiotic class, and its choice depends on the suspected organism, culture result, resistance, allergy history, and local guidance.
| Treatment approach | Main distinction | Typical clinical decision |
|---|---|---|
| Ciprofloxacin | Fluoroquinolone; inhibits bacterial DNA gyrase and topoisomerase IV | Selected for susceptible infections requiring this spectrum |
| Narrow-spectrum antibiotic | Targets a smaller group of organisms | Preferred when culture identifies a susceptible pathogen |
| Non-fluoroquinolone alternative | Uses a different bacterial target | Chosen when fluoroquinolone risks outweigh benefits |
Ciprofloxacin may offer useful Gram-negative coverage and oral treatment for selected infections. Its limitations include resistance, mineral interactions, tendon injury, neurological reactions, cardiac rhythm concerns, and a restricted role in several common infections.
Doctors generally reserve ciprofloxacin for infections where the expected bacterial coverage justifies its risk profile. A urine culture is useful in recurrent or complicated urinary infections, while respiratory or systemic infections may require different samples and treatment plans.
A practical prescribing decision includes more than the site of infection. Clinicians review kidney function, allergy history, tendon problems, neurological disease, cardiac rhythm risk, pregnancy status, and current medicines before selecting a fluoroquinolone.
The Health Products Regulatory Authority and EMA safety communications have reinforced the need to limit systemic fluoroquinolones to appropriate indications. Treatment should produce clinical improvement, yet early symptom relief does not prove that the infection has been eradicated.
Older adults can receive ciprofloxacin when the expected benefit justifies the fluoroquinolone risks. EMA safety guidance from 2023 highlights careful assessment of tendon injury, nerve symptoms, aortic disease, kidney function, and interacting medicines in this group. Age alone does not decide treatment, but reduced renal clearance and corticosteroid use can increase exposure or adverse effects.
Alcohol is not known to create the same specific disulfiram-type reaction associated with some other antibiotics, yet it can worsen dizziness, poor sleep, nausea, and impaired concentration. NHS information from 2024 supports caution because ciprofloxacin itself may affect the nervous system in some patients. Avoid alcohol if you feel dizzy, confused, unusually anxious, or unwell, and do not drive after drinking or while experiencing medicine-related impairment.
Cipro contains ciprofloxacin, which blocks DNA gyrase and topoisomerase IV. Many alternative antibiotics act on different targets, such as the bacterial cell wall or protein production, and may cover a different group of organisms. EMA prescribing principles from 2024 favour selecting the narrowest suitable option after considering culture results, resistance, allergy, kidney function, and fluoroquinolone-specific risks.
Ciprofloxacin is not routinely used in children or adolescents because developing joints and tendons require extra consideration. WHO antimicrobial guidance from 2023 and specialist paediatric practice reserve it for selected infections where the expected benefit is clear, such as specific resistant or serious infections. A child or teenager should receive it only under a paediatric prescriber’s direction, with the dose calculated for the clinical situation.
Cipro can cause dizziness, tremor, sleep disturbance, confusion, or visual symptoms in some patients. HPRA safety information from 2023 supports avoiding driving and machinery work until you know how the tablets affect you. Anyone who develops faintness, marked anxiety, reduced alertness, or impaired coordination should stop the activity and seek medical advice.
Yes, diarrhoea can occur during or after ciprofloxacin because antibiotics alter intestinal bacteria. HSE antimicrobial advice from 2024 identifies severe, persistent, bloody, or fever-associated diarrhoea as a reason for prompt medical assessment, especially after treatment has finished. Avoid self-treating severe diarrhoea with anti-motility medicines until a clinician has assessed the symptoms.
Take the tablet with water and separate it from mineral supplements, antacids, and calcium-fortified products. EMA safety guidance from 2019 supports limiting strenuous exercise when tendon pain appears, because continued loading can worsen tendon injury. Keep a consistent dosing routine, avoid sharing tablets, and report new nerve, tendon, cardiac, or severe gastrointestinal symptoms promptly.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Based on 3 reviews
I was prescribed the 500 mg tablets for a complicated urinary infection. The fever and flank discomfort improved after several days, but I had a bitter taste and restless sleep at the beginning. I kept the doses separate from my mineral supplement.
After several days 5 Nov 2026The treatment helped with the infection, and I returned to work after the worst symptoms settled. I developed aching around my heel during the course, so I stopped exercising and contacted the prescriber. The pain eased after the antibiotic plan was reviewed.
During the course 7 Oct 2026I took Cipro for a bacterial infection after testing. It worked for the infection, but diarrhoea continued for a while after the tablets ended. I had not realised that my antacid could interfere with absorption, so the timing was changed.
After the tablets ended 22 Oct 2026
